AC
INBS icon

Armistice Capital’s Intelligent Bio Solutions INBS Stock Holding History

Armistice Capital’s Portfolio INBS Stock Details INBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$435K Buy
+130,000
New +$898K 0.01% 178

Other funds holding INBS

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
CW
Curio Wealth Annapolis, Maryland $293M AUM 14.23% 1-Year Est. Return

Armistice Capital's INBS Position: Q1 2026 in Review

Armistice Capital opened a new position in Intelligent Bio Solutions (INBS) in Q1 2026: 130,000 shares worth $435K. The stake represents 0.01% of the portfolio and ranks #178 among its holdings.

9 funds tracked by Wall St. Rank hold INBS as of Q1 2026.

  • Armistice Capital held 130,000 shares of Intelligent Bio Solutions worth $435K as of Q1 2026.
  • Intelligent Bio Solutions was a new Armistice Capital position in Q1 2026.
  • Intelligent Bio Solutions made up 0.01% of Armistice Capital's portfolio in Q1 2026, its #178 holding.
  • 9 funds tracked by Wall St. Rank held Intelligent Bio Solutions as of Q1 2026.

Based on Armistice Capital's 13F filing for Q1 2026, filed 15 May 2026.